Based on Hazen’s research, Cleveland Clinic spin-off company PrognostiX had commercialized a test for myeloperoxidase–an enzyme that indicates inflammation in the artery walls of the heart, which can ...
In the words of Cleveland HeartLab CEO Jake Orville, business has “exploded” since the beginning of the year, just months after his company launched a proprietary test for cardiac inflammation under a ...
Licensed from the Cleveland Clinic, TMAO has received widespread scientific and public attention since its discovery. In 2013, the American Heart Association and the American Stroke Association ...
Cleveland HeartLab has agreed to be acquired by Quest Diagnostics, a Fortune 500 medical testing company based in New Jersey. The deal should help the Cleveland Clinic spinout company accelerate its ...
If you want to make a fast-growing company grow even faster, giving it nearly $15 million might help. Cleveland HeartLab Inc. has raised $14.7 million in venture capital in a deal led by Mutual ...
A Cleveland Clinic spinoff company formed in late 2009 as the newest entry in the field of cardiovascular technology is now poised for more growth. Cleveland HeartLab president and chief executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results